Searched for
GENE BASED DRUGS
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
- India should chart own path in treatment of rare diseases: ICMR chiefIndia is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- US Stocks: Rocket Pharma shares fall 15% despite FDA nod for childhood disorder treatmentRocket Pharmaceuticals' shares dropped significantly after gaining FDA approval for Kresladi, a gene therapy for a rare childhood immune di...
- Gene-based drugs show promise in lowering cholesterol levels, reveals new studiesThe studies published in the New England Journal of Medicine highlight the potential of gene-based drugs in lowering cholesterol levels in ...
- GenePath Diagnostics develops quantitative COVID-19 test kit for drug makersThe kit is currently being used by a couple of unidentified drug makers in India, said GenePath Diagnostics CEO Nickhil Jakatdar. He said t...
- Failing to lose weight? Understanding your genes may help you get fitMapping your entire genetic structure the startup’s GenomeKundli, gives customers an insight on predisposition to more than 100 plus geneti...
- Lupin signs second partnership for its oncology pipeline, this time with German drug maker BIBI and Lupin will together develop and commercialise a new drug called MEK inhibitor that will target specific cancer cells and potentially...
- This drug therapy offers hope for patients with hearing lossNew York, June 29 (IANS) Scientists have developed a drug that could partially restore hearing in patients with an inherited form of progre...
- Indian-US team identifies genetic target for treating colorectal cancerAlso called colon, rectal or bowel cancer, CRC is the third most common cancer in men and the second in women worldwide.
- Cause of malaria drug resistance in Southeast Asia identifiedGrowing resistance to malaria drugs in Southeast Asia is caused by a single mutated gene inside the disease-causing parasite, according to ...
- European Commission set to approve first drug based on gene therapyThe idea was conceived in the 1970s but after that, a large number of clinical trials did not result in a commercial drug.
- Customised drugs will be the way forward: RoyyuruAjay Royyuru, who heads the Computational Biology Center at IBM Research, is doing ground-breaking work in personalised, information-based ...
- Reliance LifeScience picks 74% in GeneMedixReliance LifeScience on Wednesday announced the acquisition of a 74% equity stake (1.1 billion shares) in the UK-based biotech firm.
Load More
